Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds ...
A study comparing men and women suggests much of the association arises from genetic propensity to both conditions.
A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.